LBRX · NASDAQ
LB Pharmaceuticals (LBRX) Stock Price & Fundamentals
LB Pharmaceuticals (LBRX) closed at $354.50 on Oct 9, 2026, down 0.14% from the previous close of $355.00.
Share price, past year
1Y +26.40%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $354.50 |
| Sep 30, 2026 | $362.40 |
| Aug 31, 2026 | $368.61 |
| Jul 31, 2026 | $345.35 |
| Jun 30, 2026 | $325.53 |
| May 29, 2026 | $321.25 |
| Apr 30, 2026 | $316.69 |
| Mar 31, 2026 | $295.09 |
| Feb 27, 2026 | $301.24 |
| Jan 30, 2026 | $287.28 |
| Dec 31, 2025 | $287.01 |
| Nov 28, 2025 | $285.13 |
| Oct 31, 2025 | $293.59 |
Key statistics
- Market cap
- $10.17B
- P/E (TTM)
- 15.5
- EPS (TTM)
- $22.86
- Net income (TTM)
- −$85.69M
- Shares outstanding
- 28.7M
- 52-week range
- $278.41 – $372.32
LB Pharmaceuticals's market cap is $10.17B, based on a share price of $354.50 and 28.7M shares outstanding as of Jun 30, 2026.
Financials
LB Pharmaceuticals's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
LB Pharmaceuticals reported a net loss of $25.21M in fiscal 2025.
Company profile
- Name
- LB Pharmaceuticals Inc
- Ticker
- LBRX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 575 Madison Avenue, New York, NY 10022
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001691082
Recent SEC filings
- Sep 15, 2026
- Sep 3, 2026
- Aug 11, 2026
- Aug 11, 2026
- Jul 29, 2026
- Jul 22, 2026
- Jun 10, 2026
- Jun 9, 2026
Frequently asked questions
What is LB Pharmaceuticals's stock price?
LB Pharmaceuticals (LBRX) closed at $354.50 on Oct 9, 2026, down 0.14% from the previous close of $355.00.
What is LB Pharmaceuticals's market cap?
LB Pharmaceuticals's market cap is $10.17B, based on a share price of $354.50 and 28.7M shares outstanding as of Jun 30, 2026.
What is LBRX's P/E ratio?
LB Pharmaceuticals's price-to-earnings ratio is 15.5, based on trailing twelve-month diluted EPS of $22.86.
Does LB Pharmaceuticals pay a dividend?
LB Pharmaceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from LB Pharmaceuticals Inc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures